ANIP — ANI Pharmaceuticals Inc
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
$72.53
+$0.61 (+0.85%)
ANI Pharmaceuticals Inc (ANIP) is a drug manufacturers - specialty & generic company listed on NASDAQ. It is led by Nikhil Lalwani, based in 210 Main Street West, Baudette, MN, United States, 56623, with about 897 employees. ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Latest reported ANIP revenue for 2025-09-30 was $227.8M. Net income was $50.8M. Revenue was up 7.8% from 2025-06-30 to 2025-09-30. ANIP currently screens at market cap $1.41B.
Use this ANIP page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ANIP quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ANIP SEC filings page. Lician reads the product cache first so this HTML stays unique to ANI Pharmaceuticals Inc even when a live quote feed is slow.
About ANI Pharmaceuticals Inc
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
ANIP Key Statistics
Market Cap
$1.41B
Volume
295,415
Previous Close
$74.17
Day Range
$73.56 – $74.98
EPS
-$1.04
Revenue
$614.38M
Net Income
-$18.52M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+26.2%
Profit Margin
-3.0%
Employees
897
ANIP Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $614.38M | $486.82M | $316.38M | $216.14M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$18.52M | $18.78M | -$47.90M | -$42.60M |
| EPS (Diluted) | -$1.04 | $0.85 | -$3.05 | -$3.40 |
Total Assets
$1.28B
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$144.86M
Operating Cash Flow
$64.02M
Free Cash Flow
$0.00
ANI Pharmaceuticals Inc Company Information
- President, CEO & Director
- Nikhil Lalwani
- Headquarters
- 210 Main Street West, Baudette, MN, United States, 56623
- Website
- www.anipharmaceuticals.com
- Phone
- 218 634 3500
- IPO / Founded
- 2000-05-05
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic